Injectable “satellite livers” could offer an alternative to liver transplantation March 6, 2026 The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure. MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators March 4, 2026 Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation. IMES community profile: Thomas Fryer February 25, 2026 Thomas Fryer, an IMES-based PostDoc, has a wide variety of research interests, including designing snake antivenom and novel antimicrobials. Using synthetic biology and AI to address global antimicrobial resistance threat February 13, 2026 Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed. AI algorithm enables tracking of vital white matter pathways February 13, 2026 Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease. 3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs February 4, 2026 Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms. IMES community profile: Jenna Palmer January 29, 2026 Jenna Palmer, who has been at IMES since November 2024, does many things to support the IMES community, including helping with new hires, onboarding, and appointment transactions for employees and visiting students. Why it’s critical to move beyond overly aggregated machine-learning metrics January 26, 2026 New research detects hidden evidence of mistaken correlations — and provides a method to improve accuracy. AI-generated sensors open new paths for early cancer detection January 13, 2026 Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer. MIT scientists, including an IMES faculty member, investigate memorization risk in the age of clinical AI January 9, 2026 New research, including at IMES, demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 … Next page Next Last page Last » Side navigation News Events
Injectable “satellite livers” could offer an alternative to liver transplantation March 6, 2026 The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators March 4, 2026 Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
IMES community profile: Thomas Fryer February 25, 2026 Thomas Fryer, an IMES-based PostDoc, has a wide variety of research interests, including designing snake antivenom and novel antimicrobials.
Using synthetic biology and AI to address global antimicrobial resistance threat February 13, 2026 Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
AI algorithm enables tracking of vital white matter pathways February 13, 2026 Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.
3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs February 4, 2026 Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
IMES community profile: Jenna Palmer January 29, 2026 Jenna Palmer, who has been at IMES since November 2024, does many things to support the IMES community, including helping with new hires, onboarding, and appointment transactions for employees and visiting students.
Why it’s critical to move beyond overly aggregated machine-learning metrics January 26, 2026 New research detects hidden evidence of mistaken correlations — and provides a method to improve accuracy.
AI-generated sensors open new paths for early cancer detection January 13, 2026 Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
MIT scientists, including an IMES faculty member, investigate memorization risk in the age of clinical AI January 9, 2026 New research, including at IMES, demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.
